U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363720) titled 'A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy' on Jan. 07.
Brief Summary: The main aim of this study is to assess how effective TAK-861 is for treating narcolepsy type 1 and if this effect is maintained over time. Participants will take TAK-861 for a few months and if they meet certain criteria, they will be randomly assigned (by chance, like flipping a coin) to continue taking TAK-861 or take placebo (fake medicine) for up to 4 weeks to see if their narcolepsy symptoms return.
Study Start Date: Jan. 30
Study Type: INTERVENTIONAL
Condition:
Narcolepsy Type 1 (NT1)
Narcolepsy With Cataplexy
Intervention:
DRU...